Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer
- Type
- Retraction
- Notice date
- 1/4/2025 0:00
- Journal
- International Journal of Biological Macromolecules
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.ijbiomac.2024.138914
- Original paper DOI
- 10.1016/j.ijbiomac.2023.125510